Your browser doesn't support javascript.
loading
Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women.
Liu, Hongzhong; Jiang, Ji; Chen, Zhaozhao; Zhang, Yunhui; Li, Jinyi; Hoechel, Joachim; Rohde, Beate; Zimmermann, Torsten; Schultze-Mosgau, Marcus-Hillert.
Afiliación
  • Liu H; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Beijing, China.
  • Jiang J; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Beijing, China.
  • Chen Z; Bayer AG, Clinical Pharmacology, Berlin, Germany.
  • Zhang Y; Bayer AG, Clinical Pharmacology, Berlin, Germany.
  • Li J; Bayer AG, Clinical Pharmacology, Berlin, Germany.
  • Hoechel J; Bayer AG, Clinical Pharmacology, Berlin, Germany.
  • Rohde B; Bayer AG, Clinical Pharmacology, Berlin, Germany.
  • Zimmermann T; Bayer AG, Clinical Pharmacology, Berlin, Germany.
  • Schultze-Mosgau MH; Bayer AG, Clinical Pharmacology, Berlin, Germany.
Clin Pharmacol Drug Dev ; 10(5): 486-493, 2021 05.
Article en En | MEDLINE | ID: mdl-32716091
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esteroides / Receptores de Progesterona / Posmenopausia Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esteroides / Receptores de Progesterona / Posmenopausia Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2021 Tipo del documento: Article País de afiliación: China